Aneel has been a core member of the GlobalSurg steering committee, which has delivered three international cohort studies, working with 3000 surgeons across 100 countries to collect prospective data on 40,000 patients. These studies aim at providing high quality data on surgical care in low and middle income countries (LMICs).
Following pilot work to develop a global surgery RCT proposal supported by the Joint Global Health Trials (MRC/Wellcome Trust/NIHR/UK AID), the National Institute for Health Research supported the establishment of the NIHR Unit on Global Surgery at the University of Birmingham.
As a key member of the Unit, Aneel is working with LMIC partners to co-ordinate the establishment of overseas research hubs. These are delivering the FALCON, CHEETAH, and PENGUIN trials. Aneel is the chief investigator of the novel cluster randomised CHEETAH trial, which will recruit 12,000 patients from low and middle income countries across Africa, Asia, and South America.
Aneel is the Global Chief Investigator of GlobalSurg, which has the following achievements:
- 25,000 strong surgeon network
- 150,000 patients included from 110 countries
- Seven high impact, practice changing papers
- A new pipeline for disseminating impact to surgical teams and the public
- A novel online living toolkit, to deliver global change for patients (www.surgery20205.com)
- A roadmap for research for the next 3 years to support safe and sustainable post-pandemic surgery